KevinEugenePottsMD

PubMed

• Protease inhibitors as antiviral agents.
  Patick, A. K., Potts, K. E.> ;Clin Microbiol Rev. 1998 Oct
• Estimate of the frequency of human immunodeficiency virus type 1 protease inhibitor resistance within unselected virus populations in vitro.
  Tucker, S. P., Stiebel, T. R., Potts, K. E., Smidt, M. L., Bryant, M. L.> ;Antimicrob Agents Chemother. 1998 Feb
• A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-553...
  Smidt, M. L., Potts, K. E., Tucker, S. P., Blystone, L., Stiebel, T. R., Stallings, W. C., McDonald, J. J., Pillay, D., Richman, D. D., Bryant, M. L.> ;Antimicrob Agents Chemother. 1997 Mar
• 76 citations
  Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells.
  Keith M. Channon, Michael A. Blazing, Geetha A. Shetty, Kevin E. Potts, Samuel E. George> ;Cardiovascular Research. 1996 Nov 1
• Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. Brazilian Collaborative AIDS Research Group.
  Potts, K. E., Kalish, M. L., Lott, T., Orloff, G., Luo, C. C., Bernard, M. A., Alves, C. B., Badaro, R., Suleiman, J., Ferreira, O.> ;AIDS. 1993 Sep
• V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site.
  Orloff, G. M., Kalish, M. L., Chiphangwi, J., Potts, K. E., Ou, C. Y., Schochetman, G., Dallabetta, G., Saah, A. I., Miotti, P. G.> ;AIDS Res Hum Retroviruses. 1993 Jul
• Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.
  Potts, K. E., Kalish, M. L., Bandea, C. I., Orloff, G. M., St Louis, M., Brown, C., Malanda, N., Kavuka, M., Schochetman, G., Ou, C. Y.> ;AIDS Res Hum Retroviruses. 1993 Jul
• Join now to see all